Cytotoxic T lymphocyte antigen-4 (CTLA-4) is an essential negative regulator of T cell responses. Germline Ctla4 deficiency is lethal, making investigation of the function of CTLA-4 on mature T cells challenging. To elucidate the function of CTLA-4 on mature T cells, we have conditionally ablated Ctla4 in adult mice. We show that, in contrast to germline knockout mice, deletion of Ctla4 during adulthood does not precipitate systemic autoimmunity, but surprisingly confers protection from experimental autoimmune encephalomyelitis (EAE) and does not lead to increased resistance to MC38 tumors. Deletion of Ctla4 during adulthood was accompanied by activation and expansion of both conventional CD4+Foxp3− (T conv) and regulatory Foxp3+ (T reg cel...
Immunological memory is a hallmark of adaptive immunity, a defense mechanism endowed to vertebrates ...
CTLA-4 is a T cell surface receptor essential for the negative regulation of T cell activation. In t...
Autoimmune adverse events are a concern in patients treated with blocking anti-CTLA-4-mAb for solid ...
Autoimmunity can occur when self-reactive lymphocytes of the adaptive immune system are activated up...
CTLA-4, a CD28 homologue expressed on activated T cells, binds with high affinity to the CD28 ligand...
CTLA-4 has long been associated with control of autoimmunity. A recent study by Sharpe and colleague...
Naturally occurring CD4+ regulatory T cells (T(R)) that express CD25 and the transcription factor Fo...
Cytotoxic T lymphocyte antigen-4 (CTLA-4) is a major negative regulatory molecule for T-cell activat...
Manipulation of the CD28/CTLA-4 pathway is at the heart of a number of immunomodulatory approaches u...
Cytotoxic T lymphocyte antigen-4 (CTLA-4) plays a critical role in negatively regulating T cell resp...
Cytotoxic T lymphocyte-associated antigen-4 (CTLA-4; CD152) is of pivotal importance for self-tolera...
CTLA-4 is a critical negative regulator of T cell responses and CTLA-4-deficient (CTLA-4(-/-)) mice ...
FOXP3+ regulatory T (Treg) cells are powerful regulators of the immune system, as shown by the deve...
Terminally differentiated CD8+ T cells are well described, whereas there remains considerable ambigu...
AbstractCTLA-4–deficient animals develop a fatal lymphoproliferative disorder. The cellular mechanis...
Immunological memory is a hallmark of adaptive immunity, a defense mechanism endowed to vertebrates ...
CTLA-4 is a T cell surface receptor essential for the negative regulation of T cell activation. In t...
Autoimmune adverse events are a concern in patients treated with blocking anti-CTLA-4-mAb for solid ...
Autoimmunity can occur when self-reactive lymphocytes of the adaptive immune system are activated up...
CTLA-4, a CD28 homologue expressed on activated T cells, binds with high affinity to the CD28 ligand...
CTLA-4 has long been associated with control of autoimmunity. A recent study by Sharpe and colleague...
Naturally occurring CD4+ regulatory T cells (T(R)) that express CD25 and the transcription factor Fo...
Cytotoxic T lymphocyte antigen-4 (CTLA-4) is a major negative regulatory molecule for T-cell activat...
Manipulation of the CD28/CTLA-4 pathway is at the heart of a number of immunomodulatory approaches u...
Cytotoxic T lymphocyte antigen-4 (CTLA-4) plays a critical role in negatively regulating T cell resp...
Cytotoxic T lymphocyte-associated antigen-4 (CTLA-4; CD152) is of pivotal importance for self-tolera...
CTLA-4 is a critical negative regulator of T cell responses and CTLA-4-deficient (CTLA-4(-/-)) mice ...
FOXP3+ regulatory T (Treg) cells are powerful regulators of the immune system, as shown by the deve...
Terminally differentiated CD8+ T cells are well described, whereas there remains considerable ambigu...
AbstractCTLA-4–deficient animals develop a fatal lymphoproliferative disorder. The cellular mechanis...
Immunological memory is a hallmark of adaptive immunity, a defense mechanism endowed to vertebrates ...
CTLA-4 is a T cell surface receptor essential for the negative regulation of T cell activation. In t...
Autoimmune adverse events are a concern in patients treated with blocking anti-CTLA-4-mAb for solid ...